Eli Lilly and Company (NYSE:LLY) is one of the 13 Best Low Risk High Growth Stocks to Buy. Amid carrying on new studies, the ...

Eli Lilly (LLY) recently entered a collaboration with Gate Bioscience to develop molecular gate therapeutics, a move that ...

Cost control and the advancement of its solid Phase III pipeline will be critical to long-term success. Eli Lilly has 7 molecules in Phase III development, 22 molecules in Phase II development and ...

Eli Lilly (LLY) has outperformed the S&P index and its competitors during the past 5 years, LLY has a broad product portfolio, a robust pipeline that is built to power market performance.

Lilly has 11 obesity drugs in its pipeline and wants to develop more ... Eli Lilly will invest $4.5 billion to ... Any new advances could help Lilly become the first trillion ...

INDIANAPOLIS, Feb. 2, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2022. "2023 is an inflection point for Lilly - a chance ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so. Trading at $852 per ...

Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer’s disease, ALS and other brain diseases, CEO David Ricks said.